Education
About Us
Working with TipRanks
Follow Us
Kymera Therapeutics, Inc. (KYMR)
:KYMR
Kt-621
Atopic Dermatitis
Phase II
Recruiting
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Oct 13, 2025
―
Kt-621
Atopic Dermatitis
Phase I
Active Not Recruiting
Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
Apr 09, 2025
―
Kt-621
Healthy Participants Study
Phase I
Completed
First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants
Oct 23, 2024
―
Kt-253
Advanced Solid Tumors, Acute Lymphocytic Leukemia, Myeloid Malignancies, Lymphomas
Phase I
Completed
Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
Feb 10, 2023
―
Kt-413
Non Hodgkin Lymphoma, Dlbcl, Diffuse Large B Cell Lymphoma, Myd88 Gene Mutation
Phase I
Completed
Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
Jan 18, 2022
―
Kt-333
Solid Tumors, Peripheral T-Cell Lymphoma (Ptcl), Cutaneous T-Cell Lymphoma (Ctcl), T-Cell Prolymphocytic Leukemia (T-Pll), Non Hodgkin Lymphoma (Nhl), Large Granular Lymphocytic Leukemia (Lgl-L)
Phase I
Completed
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Dec 16, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kymera Therapeutics, Inc. (KYMR) have in its pipeline
KYMR is currently developing the following drugs: Kt-621, Kt-621, Kt-621. These drug candidates are in various stages of clinical development as the company works toward FDA approval.